.jpg)
TRANSCATHETER TRICUSPID INTERVENTION: SHORT PERSPECTIVE
Sari
Introduction Around 4% of individuals who are 75 years old or older demonstrate clinically significant tricuspid regurgitation (TR). Primary tricuspid regurgitation is caused by a structural abnormality of the tricuspid valve and is present in 8-10% of patients with tricuspid valve issues. Secondary tricuspid regurgitation is frequently seen due to annular stretching resulting from right ventricular enlargement and dysfunction due to pulmonary hypertension, which is commonly associated with left-sided heart disease or atrial fibrillation. Regardless of its cause, TR results in excessive volume and heightened wall pressure, which contribute negatively to harmful remodeling and worsening of TR. Interventions to address TR are not being used enough in daily clinical practice due to higher surgical risk and patients presenting late. An extensive electronic search was performed using PubMed, Google Scholar, and ScienceDirect. The inquiry was confined to English-language publications. A manual search of relevant publications and reference lists was conducted.. Result The newly introduced transcatheter tricuspid valve interventions are designed to meet this unfulfilled requirement. Furthermore, a comprehensive evaluation of the currently available transcatheter treatments, including the primary factors for choosing patients and devices, as well as details on lingering uncertainties, is presented Discussion Both dedicated expertise and a comprehensive evaluation by a multidisciplinary Heart Team are crucial in effectively incorporating these new techniques and choosing suitable patients—an established method to assess patients with TR who are potential candidates for transcatheter procedures.
Teks Lengkap:
PDF (English)Referensi
Adamo, M., Chioncel, O., Pagnesi, M., Bayes-Genis, A., Abdelhamid, M., Anker, S.D., Antohi, E.L., Badano, L., Ben Gal, T., Böhm, M., Delgado, V., Dreyfus, J., Faletra, F.F., Farmakis, D., Filippatos, G., Grapsa, J., Gustafsson, F., Hausleiter, J., Jaarsma, T., Karam, N., Lund, L., Lurz, P., Maisano, F., Moura, B., Mullens, W., Praz, F., Sannino, A., Savarese, G., Tocchetti, C.G., van Empel, V.P.M., von Bardeleben, R.S., Yilmaz, M.B., Zamorano, J.L., Ponikowski, P., Barbato, E., Rosano, G.M.C., Metra, M., 2024. Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. Eur J Heart Fail 26, 18–33. https://doi.org/10.1002/EJHF.3106
Alqahtani, F., Berzingi, C.O., Aljohani, S., Hijazi, M., Al-Hallak, A., Alkhouli, M., 2017. Contemporary Trends in the Use and Outcomes of Surgical Treatment of Tricuspid Regurgitation. J Am Heart Assoc 6. https://doi.org/10.1161/JAHA.117.007597/SUPPL_FILE/JAH32829-SUP-0001-TABLESS1-S5.PDF
Ambrosino, M., Sangoi, M., Monzer, N., Irving, B., Fiorilli, P., Khazan, B., Goldberg, S., 2024. Tricuspid Regurgitation: A Review of Current Interventional Management. J Am Heart Assoc 13. https://doi.org/10.1161/JAHA.123.032999
Antunes, M.J., Rodríguez-Palomares, J., Prendergast, B., De Bonis, M., Rosenhek, R., Al-Attar, N., Barili, F., Casselman, F., Folliguet, T., Iung, B., Lancellotti, P., Muneretto, C., Obadia, J.F., Pierard, L., Suwalski, P., Zamorano, P., 2017. Management of tricuspid valve regurgitation: Position statement of the European Society of Cardiology Working Groups of Cardiovascular Surgery and Valvular Heart Disease. Eur J Cardiothorac Surg 52, 1022–1030. https://doi.org/10.1093/EJCTS/EZX279
Anvardeen, K., Rao, R., Hazra, S., Hay, K., Dai, H., Stoyanov, N., Birnie, D., Dwivedi, G., Chan, K.L., 2019. Prevalence and Significance of Tricuspid Regurgitation Post-Endocardial Lead Placement. JACC Cardiovasc Imaging 12, 562–564. https://doi.org/10.1016/J.JCMG.2018.07.009
Besler, C., Orban, M., Rommel, K.P., Braun, D., Patel, M., Hagl, C., Borger, M., Nabauer, M., Massberg, S., Thiele, H., Hausleiter, J., Lurz, P., 2018. Predictors of Procedural and Clinical Outcomes in Patients With Symptomatic Tricuspid Regurgitation Undergoing Transcatheter Edge-to-Edge Repair. JACC Cardiovasc Interv 11, 1119–1128. https://doi.org/10.1016/J.JCIN.2018.05.002
Braun, D., Nabauer, M., Massberg, S., Hausleiter, J., 2016. Transcatheter Repair of Primary Tricuspid Valve Regurgitation Using the MitraClip System. JACC Cardiovasc Interv 9, e153–e154. https://doi.org/10.1016/J.JCIN.2016.05.020
Chorin, E., Rozenbaum, Z., Topilsky, Y., Konigstein, M., Ziv-Baran, T., Richert, E., Keren, G., Banai, S., 2020. Tricuspid regurgitation and long-term clinical outcomes. Eur Heart J Cardiovasc Imaging 21, 157–165. https://doi.org/10.1093/EHJCI/JEZ216
Condello, F., Gitto, M., Stefanini, G.G., 2021. Etiology, epidemiology, pathophysiology and management of tricuspid regurgitation: an overview. Rev Cardiovasc Med 22, 1115–1142. https://doi.org/10.31083/J.RCM2204122
Dahou, A., Ong, G., Hamid, N., Avenatti, E., Yao, J., Hahn, R.T., 2019. Quantifying Tricuspid Regurgitation Severity: A Comparison of Proximal Isovelocity Surface Area and Novel Quantitative Doppler Methods. JACC Cardiovasc Imaging 12, 560–562. https://doi.org/10.1016/J.JCMG.2018.11.015
Dhoble, A., Zhao, Y., Vejpongsa, P., Loghin, C., Smalling, R.W., Estrera, A., Nguyen, T.C., 2019. National 10-year trends and outcomes of isolated and concomitant tricuspid valve surgery. J Cardiovasc Surg (Torino) 60, 119–127. https://doi.org/10.23736/S0021-9509.18.10468-X
Donà, C., Goliasch, G., Schneider, M., Hengstenberg, C., Mascherbauer, J., 2021. Transcatheter TricValve implantation for the treatment of severe tricuspid regurgitation. Eur Heart J Cardiovasc Imaging 22, E92. https://doi.org/10.1093/EHJCI/JEAA348
Dreger, H., Mattig, I., Hewing, B., Knebel, F., Lauten, A., Lembcke, A., Thoenes, M., Roehle, R., Stangl, V., Landmesser, U., Grubitzsch, H., Stangl, K., Laule, M., 2020. Treatment of Severe TRIcuspid regurgitation in patients with advanced heart failure with caval vein implantation of the edwards sapien XT valve (TRICAVAL): A randomised controlled trial. EuroIntervention 15, 1506–1513. https://doi.org/10.4244/EIJ-D-19-00901
Dreyfus, J., Flagiello, M., Bazire, B., Eggenspieler, F., Viau, F., Riant, E., Mbaki, Y., Bohbot, Y., Eyharts, D., Senage, T., Dubrulle, H., Nicol, M., Doguet, F., Nguyen, V., Coisne, A., Le Tourneau, T., Lavie-Badie, Y., Tribouilloy, C., Donal, E., Tomasi, J., Habib, G., Selton-Suty, C., Raffoul, R., Iung, B., Obadia, J.F., Messika-Zeitoun, D., 2020. Isolated tricuspid valve surgery: impact of aetiology and clinical presentation on outcomes. Eur Heart J 41, 4304–4317. https://doi.org/10.1093/EURHEARTJ/EHAA643
Hahn, R.T., Badano, L.P., Bartko, P.E., Muraru, D., Maisano, F., Zamorano, J.L., Donal, E., 2022. Tricuspid regurgitation: recent advances in understanding pathophysiology, severity grading and outcome. Eur Heart J Cardiovasc Imaging 23, 913–929. https://doi.org/10.1093/EHJCI/JEAC009
Hahn, R.T., Weckbach, L.T., Noack, T., Hamid, N., Kitamura, M., Bae, R., Lurz, P., Kodali, S.K., Sorajja, P., Hausleiter, J., Nabauer, M., 2021. Proposal for a Standard Echocardiographic Tricuspid Valve Nomenclature. JACC Cardiovasc Imaging 14, 1299–1305. https://doi.org/10.1016/J.JCMG.2021.01.012
Hamandi, M., Smith, R.L., Ryan, W.H., Grayburn, P.A., Vasudevan, A., George, T.J., DiMaio, J.M., Hutcheson, K.A., Brinkman, W., Szerlip, M., Moore, D.O., Mack, M.J., 2019. Outcomes of Isolated Tricuspid Valve Surgery Have Improved in the Modern Era. Ann Thorac Surg 108, 11–15. https://doi.org/10.1016/J.ATHORACSUR.2019.03.004
Hammerstingl, C., Schueler, R., Malasa, M., Werner, N., Nickenig, G., 2016. Transcatheter treatment of severe tricuspid regurgitation with the MitraClip system. Eur Heart J 37, 849–853. https://doi.org/10.1093/EURHEARTJ/EHV710
Höke, U., Auger, D., Thijssen, J., Wolterbeek, R., Van Der Velde, E.T., Holman, E.R., Schalij, M.J., Bax, J.J., Delgado, V., Marsan, N.A., 2014. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up. Heart 100, 960–968. https://doi.org/10.1136/HEARTJNL-2013-304673
Hołda, M.K., Zhingre Sanchez, J.D., Bateman, M.G., Iaizzo, P.A., 2019. Right Atrioventricular Valve Leaflet Morphology Redefined: Implications for Transcatheter Repair Procedures. JACC Cardiovasc Interv 12, 169–178. https://doi.org/10.1016/J.JCIN.2018.09.029
Kadri, A.N., Menon, V., Sammour, Y.M., Gajulapalli, R.D., Meenakshisundaram, C., Nusairat, L., Mohananey, Di., Hernandez, A. V., Navia, J., Krishnaswamy, A., Griffin, B., Rodriguez, L., Harb, S.C., Kapadia, S., 2019. Outcomes of patients with severe tricuspid regurgitation and congestive heart failure. Heart 105, 1813–1817. https://doi.org/10.1136/HEARTJNL-2019-315004
Kang, G., Ha, R., Banerjee, D., 2016. Pulmonary artery pulsatility index predicts right ventricular failure after left ventricular assist device implantation. J Heart Lung Transplant 35, 67–73. https://doi.org/10.1016/J.HEALUN.2015.06.009
Kavsur, R., Iliadis, C., Spieker, M., Brachtendorf, B.M., Tiyerili, V., Metze, C., Horn, P., Baldus, S., Kelm, M., Nickenig, G., Pfister, R., Westenfeld, R., Becher, M.U., 2021. Predictors and prognostic relevance of tricuspid alterations in patients undergoing transcatheter edge-to-edge mitral valve repair. EuroIntervention 17, 827–834. https://doi.org/10.4244/EIJ-D-20-01094
Kim, J.B., Spevack, D.M., Tunick, P.A., Bullinga, J.R., Kronzon, I., Chinitz, L.A., Reynolds, H.R., 2008. The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study. J Am Soc Echocardiogr 21, 284–287. https://doi.org/10.1016/J.ECHO.2007.05.022
Kwak, J.J., Kim, Y.J., Kim, M.K., Kim, H.K., Park, J.S., Kim, K.H., Kim, K.B., Ahn, H., Sohn, D.W., Oh, B.H., Park, Y.B., 2008. Development of tricuspid regurgitation late after left-sided valve surgery: a single-center experience with long-term echocardiographic examinations. Am Heart J 155, 732–737. https://doi.org/10.1016/J.AHJ.2007.11.010
Lancellotti, P., Tribouilloy, C., Hagendorff, A., Popescu, B.A., Edvardsen, T., Pierard, L.A., Badano, L., Zamorano, J.L., 2013. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 14, 611–644. https://doi.org/10.1093/EHJCI/JET105
Lebehn, M.A., Hahn, R.T., 2023. Valvular Heart Failure due to Tricuspid Regurgitation: Surgical and Transcatheter Management Options. Heart Fail Clin 19, 329–343. https://doi.org/10.1016/J.HFC.2023.02.003
Lu, F.L., An, Z., Ma, Y., Song, Z.G., Cai, C.L., Li, B.L., Zhou, G.W., Han, L., Wang, J., Bai, Y.F., Liu, X.H., Wang, J.F., Meng, X., Zhang, H.B., Yang, J., Dong, N.G., Hu, S.S., Pan, X. Bin, Cheung, A., Qiao, F., Xu, Z.Y., 2021. Transcatheter tricuspid valve replacement in patients with severe tricuspid regurgitation. Heart 107, 1664–1670. https://doi.org/10.1136/HEARTJNL-2020-318199
Lurz, P., Orban, M., Besler, C., Braun, D., Schlotter, F., Noack, T., Desch, S., Karam, N., Kresoja, K.P., Hagl, C., Borger, M., Nabauer, M., Massberg, S., Thiele, H., Hausleiter, J., Rommel, K.P., 2020. Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair. Eur Heart J 41, 2785–2795. https://doi.org/10.1093/EURHEARTJ/EHAA138
Lurz, P., Stephan von Bardeleben, R., Weber, M., Sitges, M., Sorajja, P., Hausleiter, J., Denti, P., Trochu, J.N., Nabauer, M., Tang, G.H.L., Biaggi, P., Ying, S.W., Trusty, P.M., Dahou, A., Hahn, R.T., Nickenig, G., 2021. Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid Regurgitation. J Am Coll Cardiol 77, 229–239. https://doi.org/10.1016/J.JACC.2020.11.038
Mehr, M., Karam, N., Taramasso, M., Ouarrak, T., Schneider, S., Lurz, P., von Bardeleben, R.S., Fam, N., Pozzoli, A., Lubos, E., Boekstegers, P., Schillinger, W., Plicht, B., Eggebrecht, H., Baldus, S., Senges, J., Maisano, F., Hausleiter, J., Connelly, K., Denti, P., Schiavi, D., Weber, M., Nickenig, G., Frerker, C., Sievert, H., Vaskelyte, L., Schäfer, U., Kalbacher, D., Deuschl, F., Kuck, K.H., Allessandrini, H., Besler, C., Rommel, K.P., Ruf, T., Orban, M., Stocker, T., Deseive, S., Braun, D., Näbauer, M., Massberg, S., Bekeredjian, R., Meyer-Zuern, C.S., Pedrazzini, G., Biasco, L., 2020. Combined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe MR and TR: An Analysis From the TriValve and TRAMI Registries. Cardiovascular Interventions 13, 543–550. https://doi.org/10.1016/J.JCIN.2019.10.023
Montorfano, M., Beneduce, A., Ancona, M.B., Ancona, F., Sgura, F., Romano, V., Ferri, L.A., Bellini, B., Khawaja, S.A., Moroni, F., Chieffo, A., Carlino, M., Agricola, E., 2019. Tricento Transcatheter Heart Valve for Severe Tricuspid Regurgitation: Procedural Planning and Technical Aspects. JACC Cardiovasc Interv 12, e189–e191. https://doi.org/10.1016/J.JCIN.2019.07.010
Muraru, D., Badano, L.P., Nagata, Y., Surkova, E., Nabeshima, Y., Genovese, D., Otsuji, Y., Guida, V., Azzolina, D., Palermo, C., Takeuchi, M., 2020. Development and prognostic validation of partition values to grade right ventricular dysfunction severity using 3D echocardiography. Eur Heart J Cardiovasc Imaging 21, 10–21. https://doi.org/10.1093/EHJCI/JEZ233
Nath, J., Foster, E., Heidenreich, P.A., 2004. Impact of Tricuspid Regurgitation on Long-Term Survival. J Am Coll Cardiol 43, 405–409. https://doi.org/10.1016/j.jacc.2003.09.036
Nickenig, G., Weber, M., Lurz, P., von Bardeleben, R.S., Sitges, M., Sorajja, P., Hausleiter, J., Denti, P., Trochu, J.N., Näbauer, M., Dahou, A., Hahn, R.T., 2019. Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study. The Lancet 394, 2002–2011. https://doi.org/10.1016/S0140-6736(19)32600-5
Nishimura, R.A., Otto, C.M., Bonow, R.O., Carabello, B.A., Erwin, J.P., Guyton, R.A., O’Gara, P.T., Ruiz, C.E., Skubas, N.J., Sorajja, P., Sundt, T.M., Thomas, J.D., 2014. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63. https://doi.org/10.1016/J.JACC.2014.02.536
Prihadi, E.A., Van Der Bijl, P., Gursoy, E., Abou, R., Mara Vollema, E., Hahn, R.T., Stone, G.W., Leon, M.B., Ajmone Marsan, N., Delgado, V., Bax, J.J., 2018. Development of significant tricuspid regurgitation over time and prognostic implications: new insights into natural history. Eur Heart J 39, 3574–3581. https://doi.org/10.1093/EURHEARTJ/EHY352
Schlotter, F., Miura, M., Kresoja, K.P., Alushi, B., Alessandrini, H., Attinger-Toller, A., Besler, C., Biasco, L., Braun, D., Brochet, E., Connelly, K.A., De Bruijn, S., Denti, P., Estevez-Loureiro, R., Fam, N., Gavazzoni, M., Himbert, D., Ho, E., Juliard, J.M., Kalbacher, D., Kaple, R., Kreidel, F., Latib, A., Lubos, E., Ludwig, S., Mehr, M., Monivas, V., Nazif, T., Nickenig, G., Pedrazzini, G., Pozzoli, A., Praz, F., Puri, R., Rodés-Cabau, J., Rommel, K.P., Schäfer, U., Schofer, J., Sievert, H., Tang, G.H.L., Thiele, H., Unterhuber, M., Vahanian, A., Von Bardeleben, R.S., Von Roeder, M., Webb, J.G., Weber, M., Wild, M.G., Windecker, S., Zuber, M., Hausleiter, J., Maisano, F., Leon, M.B., Hahn, R.T., Lauten, A., Taramasso, M., Lurz, P., 2021. Outcomes of transcatheter tricuspid valve intervention by right ventricular function: A multicentre propensity-matched analysis. EuroIntervention 17, 343–352. https://doi.org/10.4244/EIJ-D-21-00191
Song, H., Kim, M.J., Chung, C.H., Choo, S.J., Song, M.G., Song, J.M., Kang, D.H., Lee, J.W., Song, J.K., 2009. Factors associated with development of late significant tricuspid regurgitation after successful left-sided valve surgery. Heart 95, 931–936. https://doi.org/10.1136/HRT.2008.152793
Taramasso, M., Benfari, G., van der Bijl, P., Alessandrini, H., Attinger-Toller, A., Biasco, L., Lurz, P., Braun, D., Brochet, E., Connelly, K.A., de Bruijn, S., Denti, P., Deuschl, F., Estevez-Loureiro, R., Fam, N., Frerker, C., Gavazzoni, M., Hausleiter, J., Ho, E., Juliard, J.M., Kaple, R., Besler, C., Kodali, S., Kreidel, F., Kuck, K.H., Latib, A., Lauten, A., Monivas, V., Mehr, M., Muntané-Carol, G., Nazif, T., Nickening, G., Pedrazzini, G., Philippon, F., Pozzoli, A., Praz, F., Puri, R., Rodés-Cabau, J., Schäfer, U., Schofer, J., Sievert, H., Tang, G.H.L., Thiele, H., Topilsky, Y., Rommel, K.P., Delgado, V., Vahanian, A., Von Bardeleben, R.S., Webb, J.G., Weber, M., Windecker, S., Winkel, M., Zuber, M., Leon, M.B., Hahn, R.T., Bax, J.J., Enriquez-Sarano, M., Maisano, F., 2019. Transcatheter Versus Medical Treatment of Patients With Symptomatic Severe Tricuspid Regurgitation. J Am Coll Cardiol 74, 2998–3008. https://doi.org/10.1016/J.JACC.2019.09.028
Toggweiler, S., De Boeck, B., Brinkert, M., Buhmann, R., Bossard, M., Kobza, R., Cuculi, F., 2018. First-in-man implantation of the Tricento transcatheter heart valve for the treatment of severe tricuspid regurgitation. EuroIntervention 14, 758–761. https://doi.org/10.4244/EIJ-D-18-00440
Topilsky, Y., Maltais, S., Medina Inojosa, J., Oguz, D., Michelena, H., Maalouf, J., Mahoney, D.W., Enriquez-Sarano, M., 2019. Burden of Tricuspid Regurgitation in Patients Diagnosed in the Community Setting. JACC Cardiovasc Imaging 12, 433–442. https://doi.org/10.1016/J.JCMG.2018.06.014
Topilsky, Y., Nkomo, V.T., Vatury, O., Michelena, H.I., Letourneau, T., Suri, R.M., Pislaru, S., Park, S., Mahoney, D.W., Biner, S., Enriquez-Sarano, M., 2014. Clinical outcome of isolated tricuspid regurgitation. JACC Cardiovasc Imaging 7, 1185–1194. https://doi.org/10.1016/J.JCMG.2014.07.018
Tsukashita, M., Takayama, H., Takeda, K., Han, J., Colombo, P.C., Yuzefpolskaya, M., Topkara, V.K., Garan, A.R., Mancini, D.M., Kurlansky, P.A., Naka, Y., 2015. Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival. J Thorac Cardiovasc Surg 150, 1352-1361.e2. https://doi.org/10.1016/J.JTCVS.2015.07.012
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., de Bonis, M., de Paulis, R., Delgado, V., Freemantle, N., Gilard, M., Haugaa, K.H., Jeppsson, A., Jüni, P., Pierard, L., Prendergast, B.D., Sádaba, J.R., Tribouilloy, C., Wojakowski, W., 2022. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. EuroIntervention 17, E1126–E1196. https://doi.org/10.4244/EIJ-E-21-00009
Wafae, N., Hayashi, H., Gerola, L.R., Vieira, M.C., 1990. Anatomical study of the human tricuspid valve. Surgical and Radiologic Anatomy 12, 37–41. https://doi.org/10.1007/BF02094123/METRICS
Xanthos, T., Dalivigkas, I., Ekmektzoglou, K., 2011. Anatomic variations of the cardiac valves and papillary muscles of the right heart. Ital J Anat Embryol. https://doi.org/10.13128/IJAE-10339
Zahr, F., Chadderdon, S., Song, H., Sako, E., Fuss, C., Bailey, S.R., Cigarroa, J., 2022. Contemporary diagnosis and management of severe tricuspid regurgitation. Catheter Cardiovasc Interv 100, 646–661. https://doi.org/10.1002/CCD.30364
Zoghbi, W.A., Adams, D., Bonow, R.O., Enriquez-Sarano, M., Foster, E., Grayburn, P.A., Hahn, R.T., Han, Y., Hung, J., Lang, R.M., Little, S.H., Shah, D.J., Shernan, S., Thavendiranathan, P., Thomas, J.D., Weissman, N.J., 2017. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 30, 303–371. https://doi.org/10.1016/J.ECHO.2017.01.007
DOI: https://doi.org/10.31869/mm.v7i1.5910
Article Metrics
Sari view : 0 timesPDF (English) - 0 times
Refbacks
- Saat ini tidak ada refbacks.
Kunjungan Saat ini
Kunjungan Dari Negara
Menara Medika is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.